News

CMTA is excited to report significant progress in its strategic CMTA-STAR investment of over $200,000 towards developing a human-derived organoid model for CMT1A. This pioneering research led by Professor Vincent Timmerman, PhD, at the University of Antwerp in Antwerp, Belgium, ...

With the incredible support of the CMT community, Esther Wolfs, PhD, and her team at FIERCE Lab located at Hasselt University in Belgium have made tremendous progress in their groundbreaking research to develop a new model for CMT1A using dental ...

The Charcot-Marie-Tooth Association (CMTA), in collaboration with Actio Biosciences (Actio Bio), hosted a virtual patient focus group for individuals diagnosed with Charcot-Marie-Tooth disease Type 2C (CMT2C), also known as TRPV4 Neuropathy. Engaging volunteer experts from the CMT2C patient community, the ...

THE CHARCOT-MARIE-TOOTH ASSOCIATION LAUNCHES AMAZON STOREFRONT FEATURING ASSISTIVE GADGETS & PRODUCTS FOR THE CMT COMMUNITY The Charcot-Marie-Tooth Association (CMTA) has launched a comprehensive Amazon storefront featuring assistive gadgets and products for the CMT community. CMTA earns a commission on most of ...

With CMTA support of $302,071, an international team of researchers from the Inherited Neuropathies Consortium, led by Micheal Shy, MD, at the University of Iowa in Iowa City, IA, is studying the natural history of CMT2F to learn how this ...